Accuray and RaySearch expand collaboration integrating RayStation with Accuray platforms
Accuray and RaySearch entered into a definitive agreement to expand their collaboration to accelerate Accuray’s adoption of online adaptive radiation therapy.
RaySearch Laboratories AB (publ) and Accuray Incorporated (NASDAQ: ARAY) said they have entered into a definitive agreement for an expanded collaboration designed to accelerate Accuray’s adoption of online adaptive radiation therapy. Under the agreement, Accuray will purchase RayStation treatment planning system licenses and related services for use with Accuray platforms.